Thermo Fisher Scientific logo

Thermo Fisher Scientific

TMONYSEStock Fundamentals

Thermo Fisher Scientific is a global leader in life sciences, providing a comprehensive portfolio of analytical instruments, laboratory equipment, software, and services. The company enables scientific research, clinical diagnostics, and pharmaceutical manufacturing through a combination of innovative technology and end-to-end laboratory solutions.

Market Cap$167.00B
Revenue TTM$43.4B
Net Income TTM$6.8B
P/E Ratio24.39
Net Margin15.79%
EPS TTM$18.19
Free Cash Flow TTM$6.7B
Employees122.0K
CEOMarc N. Casper
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
SegmentsLife Sciences Tools & Services, Medical Diagnostics, Biotechnology
Business ModelsManufacturing, Contract Development and Manufacturing (CDMO), Direct Sales, Distribution
Most Recent EarningsApr 23, 2026 · 1 month 2 days agoQ1 2026
View report
Next EarningsJul 22, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Op. Margin17.14%
ROE13.52%
D/E83.11%
Current Ratio1.53
Total Debt$43.2B
Cash$3.3B
CapEx TTM$1.5B

Net Income

View metric

Operating Cash Flow

View metric

Free Cash Flow

View metric

EPS (Diluted)

View metric

Business Segments

Life Sciences Solutions

primary

Provides a broad portfolio of reagents, instruments, and consumables used in biological and medical research, drug discovery, and production of biopharmaceuticals.

Products

Invitrogen, Applied Biosystems, Gibco, Ion Torrent

Customers

Pharmaceutical companies, Biotech companies, Academic research institutions

Laboratory Products and Biopharma Services

primary

Provides laboratory equipment, outsourced research, and pharmaceutical manufacturing services including clinical trial management.

Products

Fisher Scientific, Unity Lab Services, Patheon, PPD

Customers

Contract Research Organizations, Healthcare providers, R&D departments

Analytical Instruments

major

Offers instruments, software, and services for use in laboratory, manufacturing, and field settings across chromatography, mass spectrometry, and chemical analysis.

Products

Thermo Scientific, Electron Microscopes, Mass Spectrometers

Customers

Environmental labs, Industrial quality control, Government agencies

Specialty Diagnostics

moderate

Focuses on diagnostic test kits, reagents, and instruments used by clinical laboratories and hospitals to improve patient care.

Products

Clinical Diagnostic Kits, ImmunoDiagnostics, Microbiology products

Customers

Hospitals, Clinical diagnostic labs

Segment Financials

Life Sciences Solutions — Segment assets

View metric

Life Sciences Solutions — Restructuring and other costs

View metric

Laboratory Products and Biopharma Services — Segment assets

View metric

Laboratory Products and Biopharma Services — Restructuring and other costs

View metric

Analytical Instruments — Restructuring and other costs

View metric

Analytical Instruments — Segment assets

View metric

Specialty Diagnostics — Segment assets

View metric

Business Overview

Competitive Position

The company maintains a dominant market position as a 'one-stop shop' for scientific research, leveraging massive scale and a deep portfolio of proprietary brands.

Geographies

North America, Europe, Asia-Pacific, Rest of World

Customer Segments

Pharmaceutical and Biotech, Academic and Government, Industrial and Applied, Healthcare and Diagnostics

Upstream Dependencies

Raw material suppliers, Specialized component manufacturers, Chemical and reagent feedstock providers

Downstream Customers

Drug development pipelines, Clinical patient testing, Environmental monitoring programs, Academic research projects

Thermo Fisher Scientific logo

Thermo Fisher Scientific FAQ

Common questions about Thermo Fisher Scientific

Thermo Fisher Scientific is a global leader in life sciences, providing a comprehensive portfolio of analytical instruments, laboratory equipment, software, and services. The company enables scientific research, clinical diagnostics, and pharmaceutical manufacturing through a combination of innovative technology and end-to-end laboratory solutions.

Thermo Fisher Scientific (TMO) has a market capitalization of $167.00B and trades on NYSE.

Thermo Fisher Scientific generated $43.4B in trailing twelve-month revenue with net income of $6.8B, representing a net margin of 15.8%, with free cash flow of $6.7B. These figures are based on the Q1 2026 filing.

Thermo Fisher Scientific's key competitors include Danaher Corporation, Agilent Technologies, Waters Corporation, and others. These companies compete in similar markets and product categories.

Thermo Fisher Scientific has approximately 122,000 employees.